AskBio’s AB-1002 gene therapy receives FDA fast-track status
AskBio is enrolling participants in the Phase II GenePHIT trial of AB-1002, focusing on the treatment of CHF.
AskBio is enrolling participants in the Phase II GenePHIT trial of AB-1002, focusing on the treatment of CHF.